hit counter

Latest Treatments for Frontotemporal Dementia (FTD): High-Dose Oxytocin Emerges as the Standout (2023 Review)

Frontotemporal dementia (FTD) is a challenging and impactful neurodegenerative disease. Recent research offers new insights into its management, particularly regarding the effectiveness of pharmacological treatments. Highlights: High-Dose Oxytocin Shows Promise: High-dose oxytocin (72 international units) has been linked to significant improvements in neuropsychiatric symptoms and daily interactive activities in FTD patients. Piracetam Poses Risks: Contrarily, …

Read more

How Long Does Paxil Stay In Your System After Stopping?

Paxil (Paroxetine) is an antidepressant manufactured by GlaxoSmithKline that hit the market in 1992.  It was originally approved by the FDA for the treatment of major depression in adults.  The drug has since received FDA approval to treat a variety of other psychiatric and medical conditions including: generalized anxiety disorder, hot flashes, panic disorder, PTSD, …

Read more

Paxil vs. Placebo: 2014 Meta-Analysis with Unpublished Data Questions Drug’s Efficacy

A new meta-analysis recently showed that the antidepressant Paxil (Paroxetine) is only slightly more effective than a placebo for both depression and anxiety disorders. Prior to this finding, it was assumed that all SSRI antidepressants were significantly more effective than a placebo, hence getting approval to treat depression. In the article I wrote entitled “Do …

Read more